Amidst the excitement and promise of new immunotherapies, is the opportunity to use existing therapies in new ways to improve outcomes for patients with genitourinary cancers, delegates attending the Clinical Oncological Society of Australia annual meeting have heard. Dr Craig Gedye, from Hunter Medical Research Institute and the University of Newcastle, told the conference that ...
Repurposing old drugs as important as celebrating the new
By Mardi Chapman
14 Nov 2017